What is an Evidence Summary?
Key messages from scientific research that's ready to be acted on
Got It, Hide this
In people with 2 to 4 diabetes risk factors, high-dose atorvastatin reduced cardiovascular risk but increased new-onset diabetes compared with low-dose statins
Waters DD, Ho JE, Boekholdt SM, et al. Cardiovascular event reduction versus new-onset diabetes during atorvastatin therapy: effect of baseline risk factors for diabetes. J Am Coll Cardiol. 2013;61:148-52.
What is the effect of statins on the incidence of diabetes in people with different risks of diabetes?
Atorvastatin is a cholesterol-lowering drug of the type called statins. It prevents heart attacks and strokes. However, statins may also increase the incidence of diabetes.
How the review was done
This summary is based on an additional analysis of patient data from 2 randomized controlled trials:
- The Treating to New Targets (TNT) trial included 10,001 people 35 to 75 years of age. People were assigned to receive atorvastatin, 10 mg/day (low dose), or 80 mg/day (high dose). 50% of participants were followed for at least 4.9 years.
- The Incremental Decrease in Endpoints Through Aggressive Lipid Lowering (IDEAL) trial included 8,888 people less than 80 years of age. People were assigned to receive simvastatin, 20 to 40 mg/day, or atorvastatin, 80 mg/day. 50% of participants were followed up for at least 4.8 years.
The 2 trials were published between 2001 and 2012. Both were funded by Pfizer Inc, the company that makes atorvastatin.
Outcomes included new-onset diabetes and cardiovascular events (death from heart problems, heart attack, stroke, and resuscitated cardiac arrest).
The researchers looked at the results according to the number of diabetes risk factors people in the trials had. The 4 risk factors for developing diabetes were
- fasting blood sugar 5.6 to 6.9 mmol/L (that is, a little elevated but not high enough for the diagnosis of diabetes);
- fasting triglyceride level greater than 1.7 mmol/L;
- body mass index greater than 30 kg/m2 (that is, overweight); and
- history of high blood pressure.
What the researchers found
In people with 0 or 1 diabetes risk factor
- High-dose atorvastatin did not differ from low-dose atorvastatin or simvastatin for new-onset diabetes. Overall incidence was about 3.3%.
- Compared with low-dose atorvastatin or simvastatin, high-dose atorvastatin reduced cardiovascular events by 13% (from 9.8% to 8.5%).
In people with 2 to 4 diabetes risk factors
- Compared with low-dose atorvastatin or simvastatin, high-dose atorvastatin increased the incidence of new-onset diabetes by 24% (from 12% to 14%).
- Compared with low-dose atorvastatin or simvastatin, high-dose atorvastatin reduced cardiovascular events by 16% (from 11% to 9%).
In people with 0 or 1 risk factor for diabetes, high-dose atorvastatin (80 mg/day) reduced cardiovascular risk compared with low-dose atorvastatin (10 mg/day) or simvastatin (20 to 40 mg/day), without increasing the risk for new-onset diabetes.
In people with 2 to 4 risk factors for diabetes, high-dose atorvastatin (80 mg/day) reduced cardiovascular risk but increased incidence of new-onset diabetes compared with low-dose atorvastatin (10 mg/day) or simvastatin (20 to 40 mg/day).
High-dose atorvastatin (80 mg/day) compared with low-dose atorvastatin (10 mg/day) or simvastatin (20 to 40 mg/day)
24% relative increase
13% relative decrease
16% relative decrease
Randomized controlled trials
Studies where people are assigned to one of the treatments purely by chance.
Aspects making a condition more likely.
The body's network of blood vessels. It includes the arteries, veins, and capillaries that carry blood to and from the heart.
Related Evidence Summaries
Journal of Diabetes Science and Technology (2018)
Cochrane Database of Systematic Reviews (2014)
Cochrane Database of Systematic Reviews (2012)
Related Web Resources
This patient decision aid helps People with prediabetes considering treatment to help prevent type 2 diabetes decide on whether to make a major lifestyle change or take the medicine metformin by comparing the benefits, risks, and side effects of both options.
Harvard School of Public Health
There are three main types of fat: unsaturated, saturated and trans fat. Unsaturated fats can help improve cholesterol levels and lower inflammation and are found in olive oil, avocados, nuts, seeds and fish. Trans fats are common in fast foods, and can increase your risk of heart disease, stroke, diabetes and other chronic conditions.
Informed Health Online
Talk to your doctor about diabetes medications. Consider your treatment goals, age, weight, health conditions and other medications when deciding if a drug is right for you.
DISCLAIMER These summaries are provided for informational purposes only. They are not a substitute for advice from your own health care professional. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the McMaster Optimal Aging Portal